AUROPHARMA:NSE
Aurobindo Pharma Ltd
₹1,796.30
arrow_upward
+0.12%(+2.20) 1D
Nov 18, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AUROPHARMA...
Open
₹1,793.60
High
₹1,817.40
Low
₹1,788.70
Mkt. cap
1.03T
Avg. vol.
1.16M
Volume
1.19M
Dividend
0.39%
Quarterly dividend
₹1.75
Ex-dividend date
Nov 11, 2026
P/E ratio
27.23
52-wk high
₹1,859.90
52-wk low
₹1,106.00
EPS
₹65.98
Shares outstanding
585.90M
No. of employees
29K
Open
₹1,793.60
High
₹1,817.40
Low
₹1,788.70
Mkt. cap
1.03T
Avg. vol.
1.16M
Volume
1.19M
Dividend
0.39%
Quarterly dividend
₹1.75
Ex-dividend date
Nov 11, 2026
P/E ratio
27.23
52-wk high
₹1,859.90
52-wk low
₹1,106.00
EPS
₹65.98
Shares outstanding
585.90M
No. of employees
29K
News stories
From web sources and news partners
Moneycontrol.com
·
2 days ago
Buy Aurobindo Pharma; target of Rs 2111: Geojit Financial Services
Profile
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company based in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, Mercer County, New Jersey. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include Pfizer and AstraZeneca. Wikipedia
About Aurobindo Pharma Ltd
CEO-
Employees29.2K
Founded1986
HeadquartersHyderabad, Andhra Pradesh, India
SectorHealth Care
IndustryPharmaceutical industry
Websiteaurobindo.com